Teva Pharmaceutical Industries (TEVA) Financial Analysis & Valuation | Quarter Chart

Teva Pharmaceutical Industries (TEVA)

TEVA
Price: $33.16
Fair Value: 🔒
🔒score
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, ... more
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, a... more
Description Shares
Market Cap$38.02BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryILCEORichard D. Francis
IPO Date1982-02-16CAGR0.14%
Employees37,000Websitewww.tevapharm.com
Div. Yield—Payout Ratio—
Buy Back Yield—Total Yield—
TEVA chart loading...
Fundamentals Technicals
Enterprise Value$49.40BP/E Ratio39.3
Forward P/E11.3PEG Ratio—
P/S Ratio2.27P/B Ratio5.25
P/CF Ratio35.74P/FCF Ratio65.93
EPS$0.61EPS Growth 1Y-182.76%
EPS Growth 3Y-156.6%EPS Growth 5Y-132.97%
Revenue Growth 1Y4.32%Gross Margin0.5%
Operating Margin0.11%Profit Margin0.04%
ROE0.11%ROA0.02%
ROCE0.06%Current Ratio1.11
Quick Ratio0.82Cash Ratio0.19
Debt/Equity2.36Interest Coverage2.09
Altman Z Score1.38Piotroski Score8

View Teva Pharmaceutical Industries financial charts →